Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer

201460 citationsJournal Article

Authors

Raheleh Roudi · Iran University of Medical Sciences

Zahra Madjd · Iran University of Medical Sciences

Alireza Korourian · Iran University of Medical Sciences

Mitra Mehrazma · Iran University of Medical Sciences

Saadat Molanae · Milad Hospital

Mehrdad Nasrollahzadeh Sabet · Iran University of Medical Sciences

Ahmad Shariftabrizi

Abstract

CD44 could be a valuable tool for the study of lung CSCs and provide a novel therapeutic target for treatment of the patients with lung cancer in combination with conventional therapy.

Topics & Keywords

Cancer Cells and Metastasis Lung Cancer Research Studies Cancer Genomics and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer Biomarkers

Volume 14, Issue 6, pp. 457-467

DOI: 10.3233/cbm-140424

Field-Weighted Citation Impact: 3.52